Tim Doyle details the hyper-growth journey of his telehealth unicorn Eucalyptus and its recent $1.6 billion acquisition by Hims & Hers. The conversation reveals how focusing on scale, performance marketing, and a clear vision for chronic condition care allowed the team to build a dominant platform despite intense regulatory and public scrutiny.
Topics: telehealth, startups, acquisitions, GLP-1, Australian tech